These results suggested that the CD4+CD25hi Helios+ T cells may be a better marker for the Treg cell population than others that are currently used, and the frequency of these Helios+ identified cells also may be informative regarding disease activities and treatment with TNFi in RA patients. This evidence concerns the gene CD4 and rheumatoid arthritis.